Manzo Pharmaceut Valuation
| MNZO Stock | USD 0.0001 0.00 0.00% |
Manzo Pharmaceut seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Manzo Pharmaceut from analyzing the firm fundamentals such as Current Valuation of 11.6 K, ebitda of (4.24 M), and Revenue of 2.01 K as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Manzo Pharmaceut's valuation include:
Overvalued
Today
Please note that Manzo Pharmaceut's price fluctuation is very steady at this time. Calculation of the real value of Manzo Pharmaceut is based on 3 months time horizon. Increasing Manzo Pharmaceut's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Manzo Pharmaceut is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Manzo Stock. However, Manzo Pharmaceut's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Manzo Pharmaceut's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Manzo Pharmaceut's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Manzo Pharmaceut helps investors to forecast how Manzo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Manzo Pharmaceut more accurately as focusing exclusively on Manzo Pharmaceut's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Manzo Pharmaceut's intrinsic value based on its ongoing forecasts of Manzo Pharmaceut's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Manzo Pharmaceut's closest peers.
Manzo Pharmaceut Cash |
|
Manzo Valuation Trend
Knowing Manzo Pharmaceut's actual value is paramount for traders when making sound investment determinations. Using both Manzo Pharmaceut's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Manzo Pharmaceut Total Value Analysis
Manzo Pharmaceut is now forecasted to have valuation of 11.6 K with market capitalization of 115.95 K, debt of 11.09 K, and cash on hands of 21. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Manzo Pharmaceut fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.6 K | 115.95 K | 11.09 K | 21 |
Manzo Pharmaceut Investor Information
The company had not issued any dividends in recent years. Manzo Pharmaceut had 1:10 split on the 17th of September 2014. Based on the key indicators related to Manzo Pharmaceut's liquidity, profitability, solvency, and operating efficiency, Manzo Pharmaceut is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Manzo Pharmaceut Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Manzo suggests not a very effective usage of assets in July.Manzo Pharmaceut Profitability Analysis
The company reported the previous year's revenue of 2.01 K. Net Loss for the year was (36.24 K) with loss before overhead, payroll, taxes, and interest of (517.23 K).About Manzo Pharmaceut Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Manzo Pharmaceut. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Manzo Pharmaceut based exclusively on its fundamental and basic technical indicators. By analyzing Manzo Pharmaceut's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Manzo Pharmaceut's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Manzo Pharmaceut. We calculate exposure to Manzo Pharmaceut's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Manzo Pharmaceut's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 911.95 | 866.35 | |
| Pretax Profit Margin | (16.20) | (17.01) | |
| Operating Profit Margin | 0.45 | 0.48 | |
| Net Loss | (20.70) | (21.73) | |
| Gross Profit Margin | 0.35 | 0.37 |
Manzo Pharmaceut Current Valuation Indicators
Manzo Pharmaceut's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Manzo Pharmaceut's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Manzo Pharmaceut, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Manzo Pharmaceut's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Manzo Pharmaceut's worth.When determining whether Manzo Pharmaceut offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Manzo Pharmaceut's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Manzo Pharmaceut Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Manzo Pharmaceut Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Manzo Pharmaceut. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Manzo Stock, please use our How to Invest in Manzo Pharmaceut guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Manzo Pharmaceut. If investors know Manzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Manzo Pharmaceut listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Manzo Pharmaceut is measured differently than its book value, which is the value of Manzo that is recorded on the company's balance sheet. Investors also form their own opinion of Manzo Pharmaceut's value that differs from its market value or its book value, called intrinsic value, which is Manzo Pharmaceut's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Manzo Pharmaceut's market value can be influenced by many factors that don't directly affect Manzo Pharmaceut's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Manzo Pharmaceut's value and its price as these two are different measures arrived at by different means. Investors typically determine if Manzo Pharmaceut is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Manzo Pharmaceut's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.